chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 73-year-old female patient who received SHINGRIX for prophylaxis. On 13th March 2019, the patient received the 1st dose of SHINGRIX. On 13th March 2019, less than a day after receiving SHINGRIX, the patient experienced injection site erythema, neck pain, nausea and headache. On an unknown date, the outcome of the injection site erythema, neck pain, nausea and headache were recovered/resolved. It was unknown if the reporter considered the injection site erythema, neck pain, nausea and headache to be related to SHINGRIX. Additional details were provided as follows: The reporter was the patient's sister.
Chills, nausea, weakness, overall malaise to the extreme.  24 hours duration.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The concurrent condition, medical history and concomitant medication was not reported. On 17-SEP-2015, the patient was vaccinated with an expired dose of ZOSTAVAX (lot # J012660, 10-JAN-2015) subcutaneously (expired product administration). No adverse effect was reported. No product quality issue was involved. Additional information has been requested.
dizzy scrambled vision when turning over in bed early morning  little unstable when i get up but stops shortly after i get up  has happened 2 days in row
Pink/red skin color around injection site; hardness of skin around injection site; itchy; warm to the touch ("Covid arm")
Mother called reporting child developed "fevers" 2/21/20. Unsure of time as patient was with grandmother. Grandmother does not have thermometer, but states patient his warm to the touch, sweaty, and developed diarrhea later in the evening. Symptoms continued into 2/22/20. Patient was given children's Tylenol and children's ibuprofen at approx. 2:30AM Sunday which helped reduce "fever" but returned later 2/23/20.  Mother advised to bring patient to be evaluated by PCP or walk in provider.
This occurred while EMS was on standby at the COVID vaccination clinic. The patient stated she started getting itchy skin after her COVID vaccination. Her scheduled appointment time was 12:40pm, but she arrived later for her vaccine. Patient asked for Benadryl. Patient did not have any other symptoms besides itching. At 1:38pm the patient assessment was done and vitals taken. Patient HR was 60 and RR was 20, BP was not taken. Patient was given 25 mg oral Benadryl at 1:45pm. Patient was asked to stay an additional 15 minutes for observation, and after that time she felt fine. Patient stated she was staying at work and in her office which was close to the vaccination area. Patient denied further care and transport to
Cotton mouth; Rapid heart beat; Tiredness; Nauseous; Dizzy; Mild bodyaches; Headache; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Aug2021 13:15 (Lot number: 2w0175) at the age of 38 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRY MOUTH (non-serious) with onset 25Aug2021 19:00, outcome "recovering", described as "Cotton mouth"; HEART RATE INCREASED (non-serious) with onset 25Aug2021 19:00, outcome "recovering", described as "Rapid heart beat"; FATIGUE (non-serious) with onset 25Aug2021 19:00, outcome "recovering", described as "Tiredness"; NAUSEA (non-serious) with onset 25Aug2021 19:00, outcome "recovering", described as "Nauseous"; DIZZINESS (non-serious) with onset 25Aug2021 19:00, outcome "recovering", described as "Dizzy"; PAIN (non-serious) with onset 25Aug2021 19:00, outcome "recovering", described as "Mild bodyaches"; HEADACHE (non-serious) with onset 25Aug2021 19:00, outcome "recovering", described as "Headache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dry mouth, heart rate increased, fatigue, nausea, dizziness, pain, headache.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Employee reported mild nausea for a few minutes but resolved. Reported feeling well after 15 minutes of monitoring.
tachycardia with mild exertion; Baseline HR elevated; dyspnea; palpitation; chest tightness; This is a spontaneous report from a contactable physician (patient). A 35-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot: EJ1685) via an unspecified route of administration in left arm on 29Dec2020 15:30 at single dose for COVID-19 immunization. There was no medical history, no known allergies, no allergies to medications, food, or other products. There were no concomitant medications.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, no any other medications the patient received within 2 weeks of vaccination. On 29Dec2020, 3 minutes following vaccine injection - dyspnea, palpitation and chest tightness; lasted 3-4 minutes. 24 hours later (30Dec2020) - dyspnea and tachycardia with mild exertion (1 flight of stairs). Baseline HR elevated. No treatment was received for the adverse events. Events outcome was recovering.
3 week old baby had a high fever. Was hospitalized had to endure a spinal tap. Was never given an actual cause. Dr.'s said it must be a virus. Reaction occurred 2 weeks & 6 days after vaccine. Next time the same vaccine was given 01/27/1997 child had the same reaction 2 weeks and 2 days 02/12/1997 after vaccine.
little tired; not feeling like herself; a little bit of a sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Feb2021 (Lot number: EN6202) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 25Feb2021, outcome "recovered" (26Feb2021), described as "little tired"; FEELING ABNORMAL (non-serious) with onset 25Feb2021, outcome "recovered" (26Feb2021), described as "not feeling like herself"; PAIN IN EXTREMITY (non-serious) with onset 25Feb2021, outcome "recovered" (26Feb2021), described as "a little bit of a sore arm".  Additional information: It was reported that by the end of Friday (26Feb2021) within 24 hours, she was feeling okay and normal.    No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021253394 same reporter and product, similar event; different patient
Extreme fatigue/exhaustion, sore arm, clumsy for the entire day following second vaccine.  Symptoms went away on the second day following the vaccine.  Several nurse friends suggested to report this side effect.
Friday the 12th I had flu-like systems all day.   Saturday the 13th at 6 am I woke to go the bathroom.  Upon stepping out of bed I collapsed to the tile floor, cutting my arm and head. My legs and arms would not function.  I squirmed on the floor for about fifteen minutes but was unable to stand up. Finally, I did and was able to slowly make my way to the bathroom.
Child went to sleep shortly after vaccinations. After waking up about 3 hours later, child was crying with a very high pitch and was inconsolable. Child was offered to breastfeed, bottle feeding, rocked, held in arms and nothing would calm him down. He was shivering and screaming. An hour later, child accepted to be breastfeed and did so in a very lethargic way. He continued to breastfeed weekly through the night, but mostly sleeping. He ran a mild fever and not offered Tylenol as per instructions of the pediatrician. Child continued to be lethargic for a day and a half. Child had mild diarrhea for two days after vaccination. 3 days after vaccination, the child had an allergic reaction (rash) on the bottom but also had swollen penis and redness in the area. By the first days of august (first picture with proof is dated August 5th), the child started to show signs of eczema (seborrheic dermatitis). Shortly after, eczema expanded to all of his body including legs, arms, chest.
Tightness of chest, difficulty breathing, general body discomfort, difficulty swallowing, high blood pressure.
t102, sleepy resolved 24-48 hrs p/inject; sleepy; limp;
Felt like the flu; Shooting pain in the left arm /achy; Malaise; Nausea; Little headache; Possible mild fever; Tiny chill; Intense chest pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), CHEST PAIN (Intense chest pain), INFLUENZA LIKE ILLNESS (Felt like the flu), PAIN IN EXTREMITY (Shooting pain in the left arm /achy) and PYREXIA (Possible mild fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced CHEST PAIN (Intense chest pain). On 21-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Possible mild fever) and CHILLS (Tiny chill). On an unknown date, the patient experienced MALAISE (Malaise), INFLUENZA LIKE ILLNESS (Felt like the flu), PAIN IN EXTREMITY (Shooting pain in the left arm /achy), NAUSEA (Nausea) and HEADACHE (Little headache). At the time of the report, MALAISE (Malaise), CHEST PAIN (Intense chest pain), INFLUENZA LIKE ILLNESS (Felt like the flu), PAIN IN EXTREMITY (Shooting pain in the left arm /achy), PYREXIA (Possible mild fever), CHILLS (Tiny chill), NAUSEA (Nausea) and HEADACHE (Little headache) outcome was unknown.         No concomitant medications details were provided. No treatment medications details were provided.   This case was linked to MOD-2021-280640 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Non-Significant Follow up- Reporter email address and contact details updated.
Patient called on 9/02/2020. Patient complained of a runny nose, throat being very itchy, and allergy like symptoms on the night that she recieved the vaccination. She said she did not have any swelling or redness in the arm. She said she would take flonase and it would calm the symptoms down, but she said that the symptoms would come back. I counseled her to use an otc benadryl dose if she was experiencing another flare of the allergy symptoms. I also recommended that she go see her doctor if the symptoms continued for further treatment. She has never had any allergy related symptoms to the flu shot in the past. I talked with the patient and she did want me to submit a VAERS form.
Pain that went down arm to hand; pain that went into their chest; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Pain that went down arm to hand) and CHEST PAIN (pain that went into their chest) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A, 014M2DA and 032F21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Enlargement heart (past medical history of an enlarged heart because of their asthma), Asthma (past medical history of an enlarged heart because of their asthma), Penicillin allergy, Allergy to animal (Cats) and Adhesive tape allergy (Surgical tape).   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (Pain that went down arm to hand) and CHEST PAIN (pain that went into their chest). At the time of the report, PAIN IN EXTREMITY (Pain that went down arm to hand) and CHEST PAIN (pain that went into their chest) outcome was unknown.            No concomitant medications were reported.  On 03-Dec-2021, the patient received first booster dose of Moderna COVID-19 Vaccine.  No treatment medications were reported.
Nasal Congestion, increased mucous production, cough, sore throat then fever started 6:00 PM 10/25/2009. Symptomatic treatment eg. Motrin, Tylenol, Musenex DM, Theraflu at night
Massive Confusion. Resident usually very alert and aware, and had a huge lapse in time and span. Resident  has never exhibited this type of confusion..
sore arm; Swelling; This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced pain in arm and swelling of limb. On an unknown date, the outcome of the pain in arm and swelling of limb were unknown.   It was unknown if the reporter considered the pain in arm and swelling of limb to be related to Bexsero.  Additional details were provided as follows: This case was reported by a medical assistant. The age at vaccination was not reported. The medical assistant mentioned that the patient had experienced a sore arm and swelling after having administered Bexsero. The reporter did not agree to follow up. This case linked with US2019AMR150098 and US2019AMR150092, reported by same reporter.
I was working as the coordinator at on offsite vaccine event where primarily second doses of Pfizer Covid vaccine were being administered. I was pulled over by the nurse immediately following vaccination of the recipient. The nurse informed me that the recipient had provided her a consent form with Pfizer vaccine information and indicated that she was there for her second dose of Pfizer vaccine. The nurse administered the Pfizer Covid vaccine and then reviewed the vaccination record card presented by the recipient at which time she discovered that the first document a dose of Covid vaccine was Moderna. She immediately informed the recipient and the recipient did acknowledge to me that she had requested the Pfizer vaccination as her second dose because she thought that's what she had received. The recipient had received a consent form with the Pfizer lot number when she presented to the registration desk indicating that she was there to receive her second dose of Pfizer vaccine. I informed the recipient of the CDC guidance which indicates that no further doses are necessary when a mixed series of Pfizer and Moderna Covid vaccines are  administered. I suggested that she could choose to inform her healthcare provider and to certainly report any adverse effects. The recipient reported mild cramping in her left hand while we were talking to her during the post observation. And she indicated that this might have been a psycho somatic symptom. We asked the recipient to stay an additional 10 minutes beyond the 15 required minutes for observation. She reported no further issues and that the cramping in her hand had resolved. Her mother later called the health office regarding the medication error.
A pharmacist reported that a 6 year old female experienced swelling of nares, obstructed airflow, headache, nausea, vomiting and loss of appetite, 4-6 hours after receiving FluMist vaccine. The symptoms lasted for 48 hours. No other information was available at the time of report. The reporter causality is not provided. Additional information has been requested.
Patient had a red rash the size of a baseball surronding the injection site. Patient reported no swelling and no pain except some muscle soreness right where the needle entered her arm.
I have had issues with my left shoulder for nearly 2 years. Arm hurt really bad from the first day I had the vaccine. It feels like a shoulder injury or rotator cuff injury. It continued to hurt 3 weeks afterwards when I went to get the next vaccine. The pain in my arm is so bad, that I can hardly take my wallet out of my pocket. I had the other vaccine in my right arm. I believe that the needle was too long and the shot was given up to high. I told my regular family doctor who thought it was something else. We were not able to get any results after being prescribed medications such as muscle relaxers. I had an x-ray which did not show anything so I decided to go to an orthopedic doctor. I have an appointment today with the orthopedic doctor. I get the results from the MRI that was performed on me last Friday 04-22-2022.
Ringing of the ears (Tinnitus) very Loud!! Has not stopped only gotten worse!!
2 hours after getting the vaccine itching began on stomach, face, legs and arm.  I took an antihistamine and it subsided.
Chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (fever) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (fever) and HEADACHE (headache). At the time of the report, CHILLS (Chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided by Reporter.
Bursitis; This spontaneous case was reported by a consumer and describes the occurrence of BURSITIS (Bursitis) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Paralysis arm, Crying uncontrollable, Tremor, Limping, Foot drop, Hip dislocation and Leg discomfort. Concurrent medical conditions included Multiple sclerosis relapse. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On 29-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced BURSITIS (Bursitis). At the time of the report, BURSITIS (Bursitis) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details was not reported by the reporter.
Since April 9,2021, thru 05/10/2021, I have been running a constant fever,along with terrible sweats. I was recommended by my primary care physician to see an infectous disease Dr., which I have. After taking various tests , which showed no infections , Dr.  , put me on a five day course of steriod Dexamethasone 6mg 1x per day, and said that the cause is inflamation due to the Moderna vaccine. So far this course is not working as the fever and sweats continue. Waiting to be advised by DR.  as to what thed next step is.
I had my shot in my left arm Last night (02/12/2021) I noticed a slight irritation and itching on my right forearm.  Today (02/13/2021) I started rubbing and scratching on my right forearm as it increased in irritation and itching.  I looked at it and there is a long rash on it.  As I type the top of my left hand is starting to itch and top of right hand as well but no  definitive visible rash.
This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 55-year-old female patient who received SHINGRIX for prophylaxis. On 27th June 2018, the patient received the 1st dose of SHINGRIX .5 ml. In June 2018, less than a week after receiving SHINGRIX, the patient experienced general body pain, sleep excessive and tiredness. On an unknown date, the outcome of the general body pain, sleep excessive and tiredness were recovered/resolved. It was unknown if the reporter considered the general body pain, sleep excessive and tiredness to be related to SHINGRIX. Additional details were provided as follows: The reporter was a patient who received SHINGRIX on left arm. The reporter reported that, she experienced whole body aches, felt very tired, and slept a lot and these events resolved about 48 hours after the shot. The patient had denied permission to contact their physician.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: patient called stating.. had "covid arm" stated became red and swollen next day... getting worse like a welt on arm.. advised patient to take benadryl and cortisone cream and if persists to seek medical attention
I started having runny nose, cough, headaches, fever, body aches, chills and diarrhea. This lasted for about 24 hours or less and then I reached out to an urgent care center. I was then given Paxlovid, and this did help but I did have a rebound case the next week. I found this out by home test.
fever, headache Narrative: 10 hours after receiving vaccine patient experienced fever of 101.2, headache and unable to get out of bed.
Pain in arm pit; swollen lymph nodes; pain in upper back left side; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Lot number: GK0928), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ASPIRIN (E.C.); VITAMIN C [ASCORBIC ACID]; SLOW FE; B COMPLEX (B50). Vaccination history included: Bnt162b2 (DOSE 3 (BOOSTER), SINGLE, Lot: FJ8762, Vaccine location=Left arm), for Covid-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for Covid-19 Immunization; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 24Jul2023 at 06:30, outcome "not recovered", described as "Pain in arm pit"; BACK PAIN (non-serious) with onset 24Jul2023 at 06:30, outcome "not recovered", described as "pain in upper back left side"; LYMPHADENOPATHY (non-serious) with onset 24Jul2023 at 06:30, outcome "not recovered", described as "swollen lymph nodes". Therapeutic measures were not taken as a result of pain in extremity, lymphadenopathy, back pain.  Additional information: Patient doesn't have covid prior or after vaccination. Vaccination date of third and fourth dose of vaccine was reported as 24Jul2023 (discrepant information).
pt recvd vax & started shaking all over; pt did not lose consciousness or have any color changes; This lated approx 1 min mom said may have had low grade fever but did not take it; contacted MD;